Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
ACC 25: The EKSTROM Trial
Author(s): Matthew J Budoff Added: 7 months ago
ACC 2025 - Outcomes from colchicine in patients with stable coronary artery disease (CAD) shows significant plaque volume progression compared to placebo at one year.Dr Matthew Budoff (UCLA Medical Centre, Los Angeles, US) joins us onsite at ACC 2025 to discuss findings from the randomized, placebo-controlled, investigator-initiated EKSTROM trial (NCT06342609; Lundquist Institute for Biomedical… View more

Intervention
Research Area(s) / Expertise:
Specialist in Internal Medicine with special training in hypertension and dyslipidemia and a genuine passion for preventive medicine; lecturer at the University of Zürich and PhD in cardiovascular research. Head of the hypertension and dyslipidemia facilities of the heart center and of the smoking cessation clinic of the university Hospital Zurich. Her research focuses on vascular research … View more
Erik Stroes
Research Area(s) / Expertise: Job title: Chairman of the lipid clinic
Prof Erik Stroes is Chairman of the lipid clinic at Amsterdam University Medical Center (UMC) in the Netherlands. Prof Stroes is a vascular internist with a longstanding track of research in the field of lipidology, inflammation and atherosclerosis. His current research foci encompass the use of CT-angiography as a guide to tailored treatment regimens, pathophysiology of Lp(a) in atherogenesis… View more
Research Area(s) / Expertise: Job title: Professor Paediatric Cardiology, Senior Consultant Cardiologist Director, Cardiac Catheterization
New Horizons in Dyslipidaemia
Author(s): Peter Libby , Kausik Ray , Erik Stroes Start date: Feb 12, 2026
Join us forNew Horizons in Dyslipidaemia, a new one-day virtual educational event, taking place on 12 February 2026, designed for healthcare professionals involved in the management of cardiovascular risk and other lipid-related health conditions.This event will explore the rapidly evolving landscape of lipid management, addressing persistent gaps between perceived and actual cardiovascular risk… View more

Prevention & Chronic Conditions
Chan Hong
Research Area(s) / Expertise: Job title: Pharmacist
Mr Chan Hong is an ambulatory Pharmacist in National Heart Centre Singapore (NHCS). He is currently involved in managing ambulatory clinics in areas of anticoagulation, smoking cessation and heart failure management. He is a keen advocate for patient empowerment and education to improve disease prevention and public health. He is currently involved in the formulation and review of Patient… View more
Obesity and CKD: The Dual Epidemic in Cardiovascular Health
Author(s): Christopher Henry Grant , Samira Bell Added: 3 weeks ago

Cardiovascular Renal Metabolic

Prevention & Chronic Conditions
The Coronary Microcirculation Re-explored
Author(s): Ahmed Elamin , Mustafa Abdimalik , Mohanad Abdelrahim , et al Added: 5 days ago

Prevention & Chronic Conditions
Kelvin Lee
Job title: Consultant Interventional Cardiologist
Prof Kelvin Lee is Consultant Interventional Cardiologist at the Lincolnshire Heart Centre with a focus on complex coronary intervention. His expertise includes intra-coronary imaging, rotational atherectomy, intravascular lithotripsy and coronary physiology using iFR and FFR. He leads the Cardiovascular Clinical Research Programme and is Cardio-Metabolic Lead and Deputy Clinical Director of… View more
Wolfgang Koenig
Research Area(s) / Expertise: Job title: Professor of Medicine/Cardiology
Wolfgang Koenig is a Professor of Medicine/Cardiology. He is a board-certified internist and interventional cardiologist specialized in intensive care medicine and has extensive experience in the molecular epidemiology of cardiovascular diseases. A former Director of the WHO-MONICA Augsburg Myocardial Infarction Register, Professor Koenig has held multiple clinical positions at the University of… View more